Skip to main content

Latest SEC Filings — Page 191

Page 191 · 30 filings scored 7+ · newest 7:00 AM ET · How scores work

Thu, Aug 1330 filings
8CLRBCellectar Biosciences, Inc.Cellectar Reports Q2 Loss, $34M Cash, and Going Concern DoubtForm 10-Q · Periodic report▼ NegativePro7AVAHAveanna Healthcare Holdings, Inc.Aveanna Q2 2026: Revenue Up 13.7%, Net Income $40.3M, Family First Acquisition ClosedForm 10-Q · Periodic report▲ Positive8VREOFVireo Growth Inc.Vireo Growth Secures $85M Revolving Credit Facility, Completes $48.7M PharmaCann AcquisitionForm 8-K · Current report▲ PositivePro8EVTLVertical Aerospace Ltd.Vertical Aerospace Finalizes $100M Financing: Cuts Note Conversion Price to $1.30, Grants Mudrick Board RightsForm 6-K · Current report▼ NegativePro8PRQRProQR Therapeutics N.V.ProQR Reports Q2 Results, Announces First Clinical Validation of Axiomer™ RNA Editing PlatformForm 6-K · Current report▲ PositivePro8YXTYXT.COM GROUP HOLDING LtdYXT.com Reports 80% Reduction in Net Loss, Strong AI Product Growth in H1 2026Form 6-K · Current report▲ PositivePro7AVAHAveanna Healthcare Holdings, Inc.Aveanna Delivers Strong Q2: Revenue Climbs 13.7%, 2026 Guidance RaisedForm 8-K · Current report▲ Positive7AEBIAebi Schmidt Holding AGAebi Schmidt Q2: Adjusted EBITDA +22%, Backlog Hits $1.28B, Guidance ReaffirmedForm 8-K · Current report▲ Positive8PTCTPTC THERAPEUTICS, INC.PTC Therapeutics Acquires BLA-Stage Fabry Disease Gene Therapy ST-920 for Up to $211MForm 8-K · Current report▲ PositivePro7AVAHAveanna Healthcare Holdings, Inc.Aveanna Q2 Revenue Up 13.7%, Raises 2026 GuidanceForm 8-K · Current report▲ Positive8AEBIAebi Schmidt Holding AGAebi Schmidt Q2 2026: Net Income Swings to $10.5M, But Material Weaknesses PersistForm 10-Q · Periodic report● NeutralPro8EVGNEvogene Ltd.Director Leon Recanati Buys $292K of Evogene Stock at $0.635Form 4 · Insider trade▲ PositivePro7PRQRProQR Therapeutics N.V.ProQR's Q2 2026 Update: Cash Runway to Mid-2028 and a Pipeline of Clinical MilestonesForm 6-K · Current report● Neutral7SMFGSumitomo Mitsui Financial Group, Inc.SMFG 13F Reveals $1.49B Ares Stake and $321M Jefferies PositionForm 13F-HR● Neutral7PSFEPaysafe LtdPaysafe Q2 Revenue Up 4%, Net Loss Widens; Refinancing Finalized, FY26 EPS Guidance SetForm 6-K · Current report● Neutral7RMTIRockwell Medical, Inc.Rockwell Medical Q2 2026: Sales Up 11%, Gross Margin Expands to 18%, Cash Flow PositiveForm 10-Q · Periodic report▲ Positive7CTRVPHepion Pharmaceuticals, Inc.Hepion 10-Q: Going Concern, $3.1M Raise, and New COOForm 10-Q · Periodic report▼ Negative8GLNGGolar LNG LtdGolar LNG Orders 4th FLNG Unit for $2.45B, Boosting Capacity 40%Form 6-K · Current report▲ PositivePro8ELMTElmet Group Co.Q2 Earnings Show Strong Revenue & Backlog Growth, IPO Boosts Cash & Cuts DebtForm 10-Q · Periodic report▲ PositivePro7BNTBrookfield Wealth Solutions Ltd.Brookfield Wealth Solutions Q2: DOE Up 23%, Total Assets Top $200BForm 6-K · Current report● Neutral7EUenCore Energy Corp.enCore Energy Launches $250M At-the-Market Offering ProgramForm 424B5 · Offering▼ Negative7LACLithium Americas Corp.Lithium Americas Q2 2026: $1.28B Cash, Thacker Pass 95% Engineered, DOE Loan AdvancesForm 10-Q · Periodic report● Neutral7SBCSBC Medical Group Holdings IncSBC Medical Q2 Revenue Up 13%, Net Income Up 335% to $11MForm 8-K · Current report▲ Positive8TPRTapestry, Inc.Tapestry's Full-Year Fiscal 2026 Results: Net Sales Up 14%, EPS $7.27, Coach Drives GrowthForm 10-K · Periodic report▲ PositivePro8FRVOFervo Energy CoFervo Energy Q2 2026: $55.9M Loss, Material Weaknesses, $7.2B BacklogForm 10-Q · Periodic report▼ NegativePro8GRABGrab Holdings LtdGrab's H1 2026 Report: $355M Profit, Superbank Gain, and $750M BuybackForm 6-K · Current report▲ PositivePro8TPRTapestry, Inc.Tapestry Beats Q4 Estimates, Raises Dividend 16%, and Initiates FY27 OutlookForm 8-K · Current report▲ PositivePro7KGEIKolibri Global Energy Inc.Kolibri Posts Record Q2 Revenue of $22.5M, Net Income Up 197%Form 6-K · Current report▲ Positive8FIGRFigure Technology Solutions, Inc.Figure Technology Solutions Reports Strong Q2 2026 Results with 132% Volume GrowthForm 8-K · Current report▲ PositivePro7NOMDNomad Foods LtdNomad Foods Q2: Margin Inflection, But EPS Guidance Cut on Refinancing CostsForm 6-K · Current report● Neutral
How Wiseek picks and scores these

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.